CHEMiCALC. The chemistry companionEDWARDS, P. A.Journal of chemical information and computer sciences. 1993, Vol 33, Num 5, pp 782-783, issn 0095-2338Article

High yield secretion of heterologous proteins in Corynebacterium glutamicum using its own Tat-type signal sequenceTERAMOTO, Hiroshi; WATANABE, Keiro; SUZUKI, Nobuaki et al.Applied microbiology and biotechnology. 2011, Vol 91, Num 3, pp 677-687, issn 0175-7598, 11 p.Article

Genetic heterogeneity of Alzheimer's disease : Complexity and advancesLAMBERT, Jean-Charles; AMOUYEL, Philippe.Psychoneuroendocrinology. 2007, Vol 32, issn 0306-4530, S62-S70, SUP1Conference Paper

pS2 protein in gastric carcinoma and normal gastric mucosa : association with clinicopathological parameters and patient survivalMÜLLER, W; BORCHARD, F.Journal of pathology. 1993, Vol 171, Num 4, pp 263-269, issn 0022-3417Article

Characterization of nectin processing mediated by presenilin-dependent gamma-secretaseKIM, Jinsook; CHANG, Allison; DUDAK, Amanda et al.Journal of neurochemistry. 2011, Vol 119, Num 5-6, pp 945-956, issn 0022-3042, 12 p.Article

The management of PS2 patients with advanced non-small cell lung cancerCHEONG, K. A; CHRYSTAL, K; HARPER, P. G et al.International journal of clinical practice (Esher). 2006, Vol 60, Num 11, pp 1493-1496, issn 1368-5031, 4 p.Article

Immunoradiometric assay of pS2 protein in breast cancer cytosolsGOUSSARD, J; LECHEVREL, C; ROUSSEL, G et al.Clinical chemistry (Baltimore, Md.). 1991, Vol 37, Num 10, pp 1759-1762, issn 0009-9147Article

Male breast cancer : clinico-pathological features, immunocytochemical characteristics and prognosisBRUCE, D. M; HEYS, S. D; PAYNE, S et al.European journal of surgical oncology. 1996, Vol 22, Num 1, pp 42-46, issn 0748-7983Article

Breast cancer-associated protein pS2 expression in tumors of the biliary tractSEITZ, G; THELSINGER, B; TOMASETTO, G et al.The American journal of gastroenterology. 1991, Vol 86, Num 10, pp 1491-1494, issn 0002-9270Article

Association of the human spasmolytic polypeptide and an estrogen-induced breast cancer protein (pS2) with human pancreatic carcinomaWELTER, C; THEISINGER, B; SEITZ, G et al.Laboratory investigation. 1992, Vol 66, Num 2, pp 187-192, issn 0023-6837Article

Expression of the pNR-2/pS2 protein in diverse human epithelial tumoursHENRY, J. A; BENNETT, M. K; PIGGOTT, N. H et al.British journal of cancer. 1991, Vol 64, Num 4, pp 677-682, issn 0007-0920Article

Induction of pS2 and hSP genes as markers of mucosal ulceration of the digestive tractRIO, M.-C; CHENARD, M.-P; WOLF, C et al.Gastroenterology (New York, NY. 1943). 1991, Vol 100, Num 2, pp 375-379, issn 0016-5085Article

ICI 164,384 : a control for investigating estrogen responsive genesBONDY, K. L; ZACHAREWSKI, T. R.Nucleic acids research. 1993, Vol 21, Num 22, pp 5277-5278, issn 0305-1048Article

Expression of the pS2 gene in normal, benign and neoplastic human stomachLUQMANI, Y; BENNETT, C; PATERSON, I et al.International journal of cancer. 1989, Vol 44, Num 5, pp 806-812, issn 0020-7136Article

Expression of growth factors and oncogenes in normal and tumor-derived human mammary epithelial cellsZAJCHOWSKI, D; BAND, V; PAUZIE, N et al.Cancer research (Baltimore). 1988, Vol 48, Num 24, pp 7041-7047, issn 0008-5472, 7 p., 1Article

Loss of pS2 protein expression is an early event of intestinal-type gastric cancerWU, M.-S; SHUN, C.-T; WANG, H.-P et al.Japanese journal of cancer research. 1998, Vol 89, Num 3, pp 278-282, issn 0910-5050Article

pS2 protein : a marker improving prediction of response to neoadjuvant tamoxifen in post-menopausal breast cancer patientsSOUBEYRAN, I; QUENEL, N; COINDRE, J.-M et al.British journal of cancer. 1996, Vol 74, Num 7, pp 1120-1125, issn 0007-0920Article

Hormonally-regulated proteins in breast secretions are markers of target organ sensitivityHARDING, C; OSUNDEKO, O; TETLOW, L et al.British journal of cancer. 2000, Vol 82, Num 2, pp 354-360, issn 0007-0920Article

S-layer protein production by Corynebacterium strains is dependent on the carbon sourceSOUAL-HOEBEKE, E; DE SOUSA-D'AURIA, C; CHAMI, M et al.Microbiology (Reading). 1999, Vol 145, pp 3399-3408, issn 1350-0872, 12Article

Expression de la protéine pS2 dans les cancers du sein hormonodépendants = Expression of the pS2 protein in hormonodependent breast cancersRIO, M. C; BELLOCQ, J. P; FOEKENS, J et al.Contraception, fertilité, sexualité. 1991, Vol 19, Num 1, pp 35-37, 3 p.Conference Paper

Prognostic value of pS2 protein and receptors for epidermal growth factor (EGD-R), insulin-like growth factor-1 (IGF-1-R) and somatostatin (SS-R) in patients with breast and ovarian cancerFOEKENS, J. A; VAN PUTTEN, W. L. J; PORTENGEN, H et al.Journal of steroid biochemistry and molecular biology. 1990, Vol 37, Num 6, pp 815-821, issn 0960-0760, 7 p.Conference Paper

Differential RNA expression of the PS2 gene in the human benign and malignant prostatic tissueCOLOMBEL, M; DANTE, R; BOUVIER, R et al.The Journal of urology. 1999, Vol 162, Num 3, pp 927-930, issn 0022-5347, 1Article

PS2 (TFF1) expression in prostate carcinoma : correlation with steroid receptor statusASMAA GABER ABDOU; HAYAM ABDEL SAMIE AIAD; SULTAN MOHAMED SULTAN et al.APMIS. Acta pathologica, microbiologica et immunologica Scandinavica. 2008, Vol 116, Num 11, pp 961-971, issn 0903-4641, 11 p.Article

Altération des profils de méthylation de l'ADN dans les cancers humains. Implication dans le contrôle de l'expression du gène pS2 = Alteration of DNA methylation patterns in human cancers. Involvement in the control of pS2 gene expressionRibieras, Stéphane; Dorè, J.-F.1995, 166 p.Thesis

Expression of an estrogen-induced breast cancer-associated protein (pS2) in benign and malignant human ovarian cystsDANTE, R; RIBIERAS, S; BALDASSINI, S et al.Laboratory investigation. 1994, Vol 71, Num 2, pp 188-192, issn 0023-6837Article